E-DRUG: WHO-led anti-counterfeiting coalition (2)
-------------------------------------------------
Dear E-druggers,
It would be wonderful if we could solve the World's problems with
technology. BUKO wants to give e-druggers some food for thought even if this
does not make it easy to "work together in harmony" (quote WHO).
We are concerned that the problem of counterfeits is not approached in the most suitable way by IMPACT. We have published a PHARMA-BRIEF SPECIAL (1/2007) on the issue. Here are a few of our doubts:
* The strong industry influence on IMPACT made the Rome declaration very
narrow and excluded the borader context of prices, equitable access and so
on.
* High figures of counterfeits are quoted without having reliable sources. A
closer look at the data makes us think that fakes and substandard products
are often muddled up.
* High tech solutions are not feasible for many developing countries
(RFID-labels are not cheap, technology, training and internet access are
needed)
* Industry keeps most data on counterfeits secret, that makes a good
analysis of the problems difficult
To read more
http://www.bukopharma.de/Service/Archiv/E2007_01_special.pdf [PDF 760 kB]
PHARMA-BRIEF SPECIAL 1/2007
List of contents:
Introduction............... 2
A complex problem
Company survey ............ 5
A lot of secrecy
The role of industry....... 7
Marketing or concerns?
Data on fake drugs........ 10
What is known?
IMPACT.................... 11
Quo vadis?
Jorg Schaaber
BUKO Pharma-Kampagne
August-Bebel-Str. 62
33602 Bielefeld
Germany
Fax +49-(0)521-63789
info@bukopharma.de
www.bukopharma.de/english